These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 32207584

  • 21. Clinical Effect of Pulmonary Artery Diameter/Ascending Aorta Diameter Ratio on Left Ventricular Reverse Remodeling in Patients With Dilated Cardiomyopathy.
    Shibata N, Hiraiwa H, Kazama S, Kimura Y, Araki T, Mizutani T, Oishi H, Kuwayama T, Kondo T, Morimoto R, Okumura T, Murohara T.
    Circ J; 2022 Jun 24; 86(7):1102-1112. PubMed ID: 35082187
    [Abstract] [Full Text] [Related]

  • 22. The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling.
    Amorim S, Campelo M, Moura B, Martins E, Rodrigues J, Barroso I, Faria M, Guimarães T, Macedo F, Silva-Cardoso J, Maciel MJ.
    Rev Port Cardiol; 2017 Oct 24; 36(10):709-716. PubMed ID: 28989069
    [Abstract] [Full Text] [Related]

  • 23. Correlation of plasma TSG-6 with cardiac function, myocardial fibrosis, and prognosis in dilated cardiomyopathy patients with heart failure.
    Xu L, Zhang Y, Kuang Y, Fang H, Ma Q.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul 28; 46(7):689-696. PubMed ID: 34382584
    [Abstract] [Full Text] [Related]

  • 24. Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Amorim S, Campelo M, Martins E, Moura B, Sousa A, Pinho T, Silva-Cardoso J, Maciel MJ.
    Rev Port Cardiol; 2016 May 28; 35(5):253-60. PubMed ID: 27118094
    [Abstract] [Full Text] [Related]

  • 25. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL.
    Am J Cardiol; 2011 Apr 01; 107(7):1065-70. PubMed ID: 21296328
    [Abstract] [Full Text] [Related]

  • 26. Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy.
    Rubiś P, Totoń-Żurańska J, Kołton-Wróż M, Wołkow P, Pitera E, Wiśniowska-Śmiałek S, Dziewięcka E, Garlitski A, Podolec P.
    Arch Med Sci; 2022 Apr 01; 18(2):480-488. PubMed ID: 35316894
    [Abstract] [Full Text] [Related]

  • 27. [Predictive factors of left ventricular reverse remodeling in patients with idiopathic or secondary dilated cardiomyopathy].
    Cai H, Fang Z, Weng Z, Jin X.
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jan 30; 38(1):81-88. PubMed ID: 33177028
    [Abstract] [Full Text] [Related]

  • 28. Myocardial microRNAs associated with reverse remodeling in human heart failure.
    Sucharov CC, Kao DP, Port JD, Karimpour-Fard A, Quaife RA, Minobe W, Nunley K, Lowes BD, Gilbert EM, Bristow MR.
    JCI Insight; 2017 Jan 26; 2(2):e89169. PubMed ID: 28138556
    [Abstract] [Full Text] [Related]

  • 29. Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy.
    Karatolios K, Chatzis G, Holzendorf V, Störk S, Richter A, Binas D, Schieffer B, Pankuweit S.
    Dis Markers; 2018 Jan 26; 2018():2958219. PubMed ID: 30018673
    [Abstract] [Full Text] [Related]

  • 30. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy.
    Dal Ferro M, Stolfo D, Altinier A, Gigli M, Perrieri M, Ramani F, Barbati G, Pivetta A, Brun F, Monserrat L, Giacca M, Mestroni L, Merlo M, Sinagra G.
    Heart; 2017 Nov 26; 103(21):1704-1710. PubMed ID: 28416588
    [Abstract] [Full Text] [Related]

  • 31. Focal fibrosis and diffuse fibrosis are predictors of reversed left ventricular remodeling in patients with non-ischemic cardiomyopathy.
    Yingchoncharoen T, Jellis C, Popovic ZB, Wang L, Gai N, Levy WC, Tang WH, Flamm S, Kwon DH.
    Int J Cardiol; 2016 Oct 15; 221():498-504. PubMed ID: 27414729
    [Abstract] [Full Text] [Related]

  • 32. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y, Inomata T, Iida Y, Iwamoto-Ishida M, Nabeta T, Ishii S, Sato T, Yanagisawa T, Mizutani T, Naruke T, Koitabashi T, Takeuchi I, Nishii M, Ako J.
    Heart Vessels; 2016 Apr 15; 31(4):545-54. PubMed ID: 25686768
    [Abstract] [Full Text] [Related]

  • 33. Impact of Autophagy on Prognosis of Patients With Dilated Cardiomyopathy.
    Kanamori H, Yoshida A, Naruse G, Endo S, Minatoguchi S, Watanabe T, Kawaguchi T, Tanaka T, Yamada Y, Takasugi N, Ishihara T, Mikami A, Miyazaki N, Nishigaki K, Minatoguchi S, Miyazaki T, Okura H.
    J Am Coll Cardiol; 2022 Mar 01; 79(8):789-801. PubMed ID: 35210034
    [Abstract] [Full Text] [Related]

  • 34. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
    Sarli B, Topsakal R, Kaya EG, Akpek M, Lam YY, Kaya MG.
    J Investig Med; 2013 Apr 01; 61(4):728-32. PubMed ID: 23429699
    [Abstract] [Full Text] [Related]

  • 35. Peripheral endothelial function may predict the effectiveness of beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Xie X, Wu B, Chen Y, Li W, Hu X, Chen J.
    Int J Cardiol; 2016 Oct 15; 221():128-33. PubMed ID: 27400309
    [Abstract] [Full Text] [Related]

  • 36. Left Ventricular Reverse Remodeling in Recent Onset Idiopathic Dilated Cardiomyopathy Using Contemporary Echo Techniques.
    Goland S, Fugenfirov I, Volodarsky I, Aronson H, Zilberman L, Shimoni S, George J.
    Isr Med Assoc J; 2018 Dec 15; 20(12):749-753. PubMed ID: 30550004
    [Abstract] [Full Text] [Related]

  • 37. Baseline Blood Pressure and Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy with Spontaneous Mechanical Alternans.
    Watanabe M, Kashimura T, Ishizuka M, Kase M, Sakai R, Fujiki S, Takayama T, Ishihara S, Ozaki K, Inomata T.
    Intern Med; 2023 Jun 15; 62(12):1707-1713. PubMed ID: 36351583
    [Abstract] [Full Text] [Related]

  • 38. Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Matsumura Y, Hoshikawa-Nagai E, Kubo T, Yamasaki N, Kitaoka H, Takata J, Doi Y, Sugiura T.
    Cardiovasc Ultrasound; 2015 Mar 25; 13():14. PubMed ID: 25880063
    [Abstract] [Full Text] [Related]

  • 39. Early Prediction of Left Ventricular Reverse Remodeling in First-Diagnosed Idiopathic Dilated Cardiomyopathy: A Comparison of Linear Model, Random Forest, and Extreme Gradient Boosting.
    Xie X, Yang M, Xie S, Wu X, Jiang Y, Liu Z, Zhao H, Chen Y, Zhang Y, Wang J.
    Front Cardiovasc Med; 2021 Mar 25; 8():684004. PubMed ID: 34422921
    [Abstract] [Full Text] [Related]

  • 40. Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction.
    Bauters C, Kumarswamy R, Holzmann A, Bretthauer J, Anker SD, Pinet F, Thum T.
    Int J Cardiol; 2013 Oct 03; 168(3):1837-40. PubMed ID: 23347612
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.